title: Ex vivo inhibition of thrombus formation by an anti-glycoprotein VI Fab fragment in non-human primates without modification of glycoprotein VI expression.
abstract: OBJECTIVE
  Glycoprotein (GP)VI is an attractive target for the development of new antithrombotic drugs. Its deficiency protects animals in several models of thrombosis, arterial stenosis and ischemia--reperfusion while inducing no major bleeding tendency. The Fab fragment of one anti-GPVI monoclonal antibody (9O12.2) inhibits all GPVI functions in vitro. The aim of this study was to determine the ex vivo effects of 9O12.2 Fab on hemostasis, coagulation and thrombosis in non-human primates.
  
  
  RESULTS
  Blood samples were collected from cynomolgus monkeys before and after (30, 90 and 150 min, 1 and 7 days) a bolus injection of 9O12.2 Fab (4 mg kg(-1)) or vehicle. Platelet counts and coagulation tests (prothrombin time, activated partial thromboplastin time) were not modified following Fab injection. The PFA-100 closure time increased during the first hours and returned to initial values on day + 1. Platelet-bound Fab was detected from 30 min to 24 h after Fab injection without GPVI depletion at any time. Collagen-induced platelet aggregation was selectively and fully inhibited at 30 min. Thrombus formation on collagen in flowing whole blood (1500 s(-1)) was delayed and decreased, and collagen-induced or tissue factor-induced thrombin generation in platelet-rich plasma was profoundly inhibited.
  
  
  CONCLUSIONS
  The anti-GPVI 9O12.2 Fab inhibits thrombus formation ex vivo in non-human primates with a composite effect on platelet activation and thrombin generation in the absence of GPVI depletion.
authors.affiliation: INSERM, U311, Strasbourg; EFS-Alsace, Strasbourg, France.
authors.forename: P
authors.initials: P
authors.lastname: Ohlmann
authors.forename: B
authors.initials: B
authors.lastname: Hechler
authors.forename: C
authors.initials: C
authors.lastname: Ravanat
authors.forename: S
authors.initials: S
authors.lastname: Loyau
authors.forename: N
authors.initials: N
authors.lastname: Herrenschmidt
authors.forename: F
authors.initials: F
authors.lastname: Wanert
authors.forename: M
authors.initials: M
authors.lastname: Jandrot-Perrus
authors.forename: C
authors.initials: C
authors.lastname: Gachet
mesh_terms: D000818:Animals; D001792:Blood Platelets / Q000378:metabolism*; D003251:Constriction, Pathologic; D004797:Enzyme-Linked Immunosorbent Assay; D005434:Flow Cytometry; D005786:Gene Expression Regulation; D007140:Immunoglobulin Fab Fragments / Q000378:metabolism*; D008252:Macaca fascicularis; D010973:Platelet Adhesiveness; D010974:Platelet Aggregation; D010980:Platelet Membrane Glycoproteins / Q000737:chemistry*; D011323:Primates; D013917:Thrombin / Q000378:metabolism; D013927:Thrombosis / Q000378:metabolism* / Q000517:prevention & control*; D013997:Time Factors
chemical_list: D007140:Immunoglobulin Fab Fragments; D010980:Platelet Membrane Glycoproteins; C098341:platelet membrane glycoprotein VI; D013917:Thrombin